BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 19194188)

  • 1. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
    Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
    J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis.
    Karapinar B; Yilmaz D; Balkan C; Akin M; Ay Y; Kvakli K
    Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood macrophage activation syndrome differs from infection-associated hemophagocytosis syndrome in etiology and outcome in Taiwan.
    Chen HH; Kuo HC; Wang L; Yu HR; Shen JM; Kwang KP; Yang KD
    J Microbiol Immunol Infect; 2007 Jun; 40(3):265-71. PubMed ID: 17639169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010.
    Imashuku S
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):35-9. PubMed ID: 21088619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
    Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
    Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of hemophagocytic lymphohistiocytosis in neonates: a nationwide survey in Japan.
    Suzuki N; Morimoto A; Ohga S; Kudo K; Ishida Y; Ishii E;
    J Pediatr; 2009 Aug; 155(2):235-8.e1. PubMed ID: 19446847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
    Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
    Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Kumar B; Aleem S; Saleh H; Petts J; Ballas ZK
    J Clin Immunol; 2017 Oct; 37(7):638-643. PubMed ID: 28871523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of hemophagocytic lymphohistiocytosis; efficacy of intravenous immunoglobulin therapy.
    Rajajee S; Ashok I; Manwani N; Rajkumar J; Gowrishankar K; Subbiah E
    Indian J Pediatr; 2014 Dec; 81(12):1337-41. PubMed ID: 24806152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
    Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
    Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey.
    Celkan T; Berrak S; Kazanci E; Ozyürek E; Unal S; Uçar C; Yilmaz S; Gürgey A
    Turk J Pediatr; 2009; 51(3):207-13. PubMed ID: 19817262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.
    Mahlaoui N; Ouachée-Chardin M; de Saint Basile G; Neven B; Picard C; Blanche S; Fischer A
    Pediatrics; 2007 Sep; 120(3):e622-8. PubMed ID: 17698967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Imashuku S; Teramura T; Tauchi H; Ishida Y; Otoh Y; Sawada M; Tanaka H; Watanabe A; Tabata Y; Morimoto A; Hibi S; Henter JI
    Haematologica; 2004 Feb; 89(2):183-8. PubMed ID: 15003893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing and treating hemophagocytic lymphohistiocytosis in the tropics: systematic review from the Indian subcontinent.
    Rajagopala S; Singh N
    Acta Med Acad; 2012; 41(2):161-74. PubMed ID: 23331391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults.
    Tseng YT; Sheng WH; Lin BH; Lin CW; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2011 Jun; 44(3):191-7. PubMed ID: 21524613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis.
    Yoon HS; Im HJ; Moon HN; Lee JH; Kim HJ; Yoo KH; Sung KW; Koo HH; Kang HJ; Shin HY; Ahn HS; Cho B; Kim HK; Lyu CJ; Lee MJ; Kook H; Hwang TJ; Seo JJ
    Pediatr Transplant; 2010 Sep; 14(6):735-40. PubMed ID: 20113424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
    Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases.
    Tristano AG
    Med Sci Monit; 2008 Mar; 14(3):RA27-36. PubMed ID: 18301366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis.
    Parikh SA; Kapoor P; Letendre L; Kumar S; Wolanskyj AP
    Mayo Clin Proc; 2014 Apr; 89(4):484-92. PubMed ID: 24581757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for early death in children with haemophagocytic lymphohistiocytosis.
    Trottestam H; Berglöf E; Horne A; Onelöv E; Beutel K; Lehmberg K; Sieni E; Silfverberg T; Aricò M; Janka G; Henter JI
    Acta Paediatr; 2012 Mar; 101(3):313-8. PubMed ID: 22017632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.